Gastrointestinal cancer drug resistance: the role of exosomal miRNAs
Mahsa SalehiDepartment of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, IranAsma VafadarDepartment of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, IranSeyyed Hossein KhatamiDepartment of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IranMortaza Taheri‐AnganehDepartment of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, IranOmid VakiliDepartment of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, IranAmir SavardashtakiDepartment of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, IranBabak NegahdariDepartment of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, IranParisa NaeliCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UKHamid BehroujHassan GhasemiAbadan University of Medical Sciences, Abadan, Iran. [email protected]Ahmad MovahedpourBehbahan Faculty of Medical Sciences, Behbahan, Iran. [email protected]
2021en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба